Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications
- 18 June 1994
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 343 (8912), 1531-1534
- https://doi.org/10.1016/s0140-6736(94)92938-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Correlation of MDR1 /P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemiaEuropean Journal of Haematology, 2009
- Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 EoHuman Molecular Genetics, 1993
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- High-resolution cytogenetic-based physical map of human chromosome 16Genomics, 1992
- Chromosome 16 abnormalities associated with myeloid malignanciesGenes, Chromosomes and Cancer, 1991
- Cytogenetics of childhood acute nonlymphocytic leukemiaCancer Genetics and Cytogenetics, 1989
- Acute myeloid leukemia with marrow hypereosinophilia and chromosome 16 abnormalityCancer Genetics and Cytogenetics, 1986
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983